Presbia PLC (LENS) Stake Boosted by Fmr LLC
Fmr LLC lifted its holdings in Presbia PLC (NASDAQ:LENS) by 0.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,568,278 shares of the medical instruments supplier’s stock after acquiring an additional 13,375 shares during the period. Fmr LLC owned 15.15% of Presbia PLC worth $5,856,000 at the end of the most recent reporting period.
Presbia PLC (LENS) opened at $3.07 on Friday. The company has a current ratio of 5.03, a quick ratio of 4.92 and a debt-to-equity ratio of 0.04.
A number of brokerages recently commented on LENS. ValuEngine raised Presbia PLC from a “strong sell” rating to a “sell” rating in a research note on Friday, September 1st. Jefferies Group LLC reissued a “buy” rating and set a $10.00 price target (down from $11.00) on shares of Presbia PLC in a research note on Friday, October 6th. Finally, Zacks Investment Research raised Presbia PLC from a “sell” rating to a “hold” rating in a research note on Tuesday, July 25th. Two research analysts have rated the stock with a sell rating and three have issued a buy rating to the company. Presbia PLC has a consensus rating of “Hold” and an average target price of $11.33.
Presbia PLC Profile
Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company’s segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States.
Want to see what other hedge funds are holding LENS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Presbia PLC (NASDAQ:LENS).
Receive News & Ratings for Presbia PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Presbia PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.